KeyBanc Capital Markets initiated coverage on Schrodinger with a new price target

12/5/23 8:08:54 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

KeyBanc Capital Markets initiated coverage of Schrodinger with a rating of Overweight and set a new price target of $38.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SDGR

Date	Price Target	Rating	Analyst
7/2/2024	$29.00	Outperform	Leerink Partners
12/5/2023	$38.00	Overweight	KeyBanc Capital Markets
5/5/2023	$60.00	Overweight	Piper Sandler
12/19/2022	$23.00	Neutral	Goldman
3/1/2022	$55.00	Buy	Citigroup
11/19/2021	$82.00 → $49.00	Overweight → Equal-Weight	Morgan Stanley
11/19/2021	$87.00	Overweight	Piper Sandler
11/11/2021	$80.00 → $52.00	Buy → Neutral	B of A Securities